Federman, Noah http://orcid.org/0000-0002-2627-6772
Article History
Received: 5 April 2022
Accepted: 23 August 2022
First Online: 6 September 2022
Competing interests
: N.F. has received honoraria from Bayer AG for speaking and advisory board participation and from Tempus Labs for advisory board participation. N.F. has received funding from <i>NIH/NCATS Grant # UL1TR001881</i>.